GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford Immunotec Global PLC (NAS:OXFD) » Definitions » PS Ratio

Oxford Immunotec Global (Oxford Immunotec Global) PS Ratio : 10.02 (As of May. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Oxford Immunotec Global PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Oxford Immunotec Global's share price is $21.99. Oxford Immunotec Global's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $2.19. Hence, Oxford Immunotec Global's PS Ratio for today is 10.02.

Warning Sign:

Oxford Immunotec Global PLC stock PS Ratio (=9.46) is close to 2-year high of 9.46

The historical rank and industry rank for Oxford Immunotec Global's PS Ratio or its related term are showing as below:

OXFD' s PS Ratio Range Over the Past 10 Years
Min: 4.87   Med: 6.36   Max: 9.46
Current: 9.46

During the past 9 years, Oxford Immunotec Global's highest PS Ratio was 9.46. The lowest was 4.87. And the median was 6.36.

OXFD's PS Ratio is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.97 vs OXFD: 9.46

Oxford Immunotec Global's Revenue per Sharefor the three months ended in Sep. 2020 was $0.75. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $2.19.

Warning Sign:

Oxford Immunotec Global PLC revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Oxford Immunotec Global was -17.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -1.40% per year.

During the past 9 years, Oxford Immunotec Global's highest 3-Year average Revenue per Share Growth Rate was 37.50% per year. The lowest was -35.40% per year. And the median was 1.05% per year.

Back to Basics: PS Ratio


Oxford Immunotec Global PS Ratio Historical Data

The historical data trend for Oxford Immunotec Global's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Immunotec Global PS Ratio Chart

Oxford Immunotec Global Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
PS Ratio
Get a 7-Day Free Trial Premium Member Only 3.99 7.11 6.06 5.64 5.98

Oxford Immunotec Global Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 5.10

Competitive Comparison of Oxford Immunotec Global's PS Ratio

For the Diagnostics & Research subindustry, Oxford Immunotec Global's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Immunotec Global's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford Immunotec Global's PS Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Immunotec Global's PS Ratio falls into.



Oxford Immunotec Global PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Oxford Immunotec Global's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=21.99/2.194
=10.02

Oxford Immunotec Global's Share Price of today is $21.99.
Oxford Immunotec Global's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Oxford Immunotec Global  (NAS:OXFD) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Oxford Immunotec Global PS Ratio Related Terms

Thank you for viewing the detailed overview of Oxford Immunotec Global's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Immunotec Global (Oxford Immunotec Global) Business Description

Traded in Other Exchanges
N/A
Address
143 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4SE
Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.
Executives
Andrew Scott Walton director 430 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark R. Klausner director C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Patricia Randall director C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Richard A Sandberg director 330 NEVEDA STREET, NEWTON MA 02460-1458
Patrick J Balthrop director C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE MD 20850
Herm Rosenman director OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, HILTON PARK, SAN DIEGO X0 OX14 4RZ
James R Tobin director C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Ronald Asbury Andrews director 5791 VAN ALLEN WAY, CARLSBAD CA 92008
Peter Wrighton-smith director, officer: Chief Executive Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Mclaughlin Matthew T E officer: Chief Financial Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Stefan C Linn officer: Chief Operating Officer C/O OXFORD IMMUNOTEC GLOBAL 940 INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Janet Louise Kidd officer: General Counsel C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Elizabeth M Keiley officer: SVP & General Counsel C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Richard M. Altieri officer: Chief Financial Officer C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Richard Wenstrup officer: Chief Medical Officer C/O OXFORD IMMUNOTEC GLOBAL, 94C INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RZ

Oxford Immunotec Global (Oxford Immunotec Global) Headlines

From GuruFocus